Advisor Partners’s AstraZeneca AZN Stock Holding History

Advisor Partners’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q2	$2.68M	Buy	40,588 +2,120	+6%	+$140K	0.19%	107
2022 Q1	$2.55M	Buy	38,468 +30	+0.1%	+$1.99K	0.16%	127
2021 Q4	$2.24M	Sell	38,438 -2,420	-6%	-$141K	0.14%	150
2021 Q3	$2.45M	Buy	40,858 +9,229	+29%	+$554K	0.17%	117
2021 Q2	$1.9M	Buy	31,629 +211	+0.7%	+$12.6K	0.12%	165
2021 Q1	$1.56M	Sell	31,418 -2,622	-8%	-$130K	0.11%	179
2020 Q4	$1.7M	Sell	34,040 -5,407	-14%	-$270K	0.13%	157
2020 Q3	$2.16M	Buy	39,447 +2,129	+6%	+$117K	0.19%	103
2020 Q2	$1.97M	Buy	37,318 +7,521	+25%	+$398K	0.18%	110
2020 Q1	$1.33M	Buy	29,797 +4,918	+20%	+$220K	0.16%	132
2019 Q4	$1.26M	Buy	24,879 +872	+4%	+$44.3K	0.13%	157
2019 Q3	$1.07M	Buy	24,007 +3,513	+17%	+$157K	0.13%	170
2019 Q2	$846K	Buy	20,494 +472	+2%	+$19.5K	0.1%	200
2019 Q1	$809K	Sell	20,022 -79	-0.4%	-$3.19K	0.1%	199
2018 Q4	$763K	Buy	20,101 +3,817	+23%	+$145K	0.12%	188
2018 Q3	$644K	Buy	16,284 +2,994	+23%	+$118K	0.09%	246
2018 Q2	$467K	Buy	13,290 +3,675	+38%	+$129K	0.08%	295
2018 Q1	$336K	Buy	9,615 +3,379	+54%	+$118K	0.06%	360
2017 Q4	$221K	Buy	+6,236	New	+$221K	0.04%	502
2016 Q1	–	Sell	-17,809	Closed	-$605K	–	374
2015 Q4	$605K	Buy	17,809 +344	+2%	+$11.7K	0.21%	128
2015 Q3	$556K	Sell	17,465 -17	-0.1%	-$541	0.23%	114
2015 Q2	$559K	Buy	17,482 +1,598	+10%	+$51.1K	0.21%	138
2015 Q1	$543K	Sell	15,884 -946	-6%	-$32.3K	0.23%	127
2014 Q4	$611K	Buy	16,830 +160	+1%	+$5.81K	0.27%	111
2014 Q3	$595K	Buy	16,670 +150	+0.9%	+$5.35K	0.34%	93
2014 Q2	$614K	Sell	16,520 -48	-0.3%	-$1.78K	0.3%	105
2014 Q1	$537K	Sell	16,568 -218	-1%	-$7.07K	0.29%	113
2013 Q4	$498K	Buy	16,786 +984	+6%	+$29.2K	0.29%	107
2013 Q3	$410K	Buy	15,802 +544	+4%	+$14.1K	0.29%	114
2013 Q2	$361K	Buy	+15,258	New	+$361K	0.3%	114